Merck and Moderna say experimental mRNA melanoma vaccine shows promising results

Merck and Moderna announced positive results earlier this week in a late-stage trial of a skin cancer treatment. KYW Newsradio’s Matt Coughlin spoke with local researchers about the experimental vaccine. (Photo Illustration by Nikolas Kokovlis/NurPhoto via Getty Images)